Table 4.
Region | ||||
---|---|---|---|---|
Capital | Zealand | Central Denmark | Total | |
Tested, ≥70 y, n | ||||
Nonreactive, n | 439 | 452 | 288 | 1179 |
Reactive, n | 10 | 9 | <5 | 22 |
Total, n | 449 | 461 | 291 | 1201 |
≥70 years, seroprevalence | ||||
Unadjusted, % | 2.2 (1.1–4.1) | 2.0 (0.9–3.7) | 1.0 (0.2–3.0) | 1.8 (1.2–2.8) |
Adjusted, % | 2.2 (0.6–4.1) | 1.9 (0.4–3.7) | 0.7 (−0.4–3.0) | 1.4 (0.3–2.5) |
Citizens, ≥70 y, n | 231 731 | 139 827 | 184 324 | 555 882 |
Expected seropositives, n | 5098 (1390–9501) | 2656 (559–5174) | 1290 (0–5529) | 7782 (1668–13 897) |
Confirmed cases, n | 1194 | 394 | 243 | 1831 |
Ratio of confirmed cases to expected seropositives, % | 23.4 (12.6–85.9) | 14.8 (7.6–70.5) | 18.8 (4.4–100) | 23.5 (13.2–100) |
Confirmed deaths, n | 311 | 107 | 60 | 478 |
IFR, % | 6.1 (3.3–22.4) | 4.0 (2.1–19.1) | 4.7 (1.1–100) | 6.1 (3.4–28.6) |
Tested, 17–69 y, n | ||||
Nonreactive, n | 479 | 243 | 355 | 1077 |
Reactive, n | 21 | 7 | 5 | 33 |
Total, n | 500 | 250 | 360 | 1110 |
17–69 y, seroprevalence | ||||
Unadjusted, % | 4.2 (2.6–6.3) | 2.8 (1.1–5.7) | 1.4 (0.5–3.2) | 3.0 (2.1–4.1) |
Adjusted, % | 3.9 (2.1–6.0) | 2.5 (0.6–5.3) | 1.1 (−0.3–2.8) | 2.5 (1.3–3.8) |
Citizens, 17–69 y, n | 1 268 536 | 544 560 | 887 939 | 2 701 035 |
Expected seropositives, n | 49 472 (26 639–76 112) | 13 614 (3267–28 861) | 9767 (0–24 862) | 67 525 (35 113–102 639) |
Confirmed cases, n | 5575 | 1543 | 1320 | 8438 |
Ratio of confirmed cases to expected seropositives, % | 11.3 (7.3–20.9) | 11.3 (5.3–47.2) | 13.5 (5.3–100) | 12.5 (8.2–24.0) |
Confirmed deaths, n | 45 | 17 | 9 | 71 |
IFR, % | 0.09 (0.06 –0.17) | 0.12 (0.06–0.52) | 0.09 (0.04–100) | 0.11 (0.07–0.2) |
Abbreviations: IFR, infection fatality rate; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.